Join us for an introduction to the NeuroNode 3.0, NeuroNode controller application, and the NeuroNode Trilogy as a speech-generating device that offers a flexible solution to AAC. Highlights of this ...
Control Bionics secures deal with Tobii Dynavox, global leader with augmentative and alternative communication solutions Tobii Dynavox will evaluate Control Bionics’ (ASX:CBL) NeuroNode for a ...
Offering touch control, eye control, and NeuroNode™ 3.0 control within the same system, the GridPad Trilogy is a unique 3-in-1 AAC device that progresses and grows with clients and their abilities. It ...
Dean Walsh is 32 and for the past five years he hasn't been able to walk, eat or even speak. It is the result of a brain injury sustained when he was involved in a car accident near his hometown of ...
Control Bionics to benefit from new HCPCS code in US identifying NeuroNode as reimbursable medical device New code will enable reimbursement of almost US$4300, marking a significant milestone in ...
With a background in investment banking, Control Bionics CEO Jeremy Steele appreciates the commercial realities of gaining a foothold in the US medical device market. That is: it’s not easy. Initially ...
Special Report: Control Bionics has inked an exclusive distribution agreement with Smart Box Ltd, a leading provider of assistive technology in the UK, for the sale of its innovative NeuroNode device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results